2019-07-27 17:37:00 Sat ET
stock market gold oil stock return s&p 500 asset market stabilization asset price fluctuations stocks bonds currencies commodities funds term spreads credit spreads fair value spreads asset investments
Capital gravitates toward key profitable mutual funds until the marginal asset return equilibrates near the core stock market benchmark. As Stanford finance professor Jonathan Berk suggests, capital flows equilibrate persistent mutual fund returns relative to the stock market benchmarks. Since investors first direct capital to the best active mutual fund managers, these fund managers receive so much money that it affects their ability to generate superior returns. The average return declines to fit the average return for the second-best fund managers. At this stage, investors become indifferent to investing with the first-best and second-best fund managers, so capital flows equilibrate until their average return declines to match the average return for the third-best fund managers.
This process continues until the average return of investing in most active mutual funds declines to match the stock market benchmark. Capital flows can thus reflect persistent asset returns in the transition toward the dynamic equilibrium outcome. Only high-skill fund managers can consistently earn superior average returns when numerous fund managers compete for scarce capital flows. The rationale suggests that investors who choose to invest with active fund managers cannot expect to receive positive excess returns after we apply appropriate risk and fee adjustments.
If any of our AYA Analytica financial health memos (FHM), blog posts, ebooks, newsletters, and notifications etc, or any other form of online content curation, involves potential copyright concerns, please feel free to contact us at service@ayafintech.network so that we can remove relevant content in response to any such request within a reasonable time frame.
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2019-12-22 08:30:00 Sunday ET

European Commission President Ursula von der Leyen now protects the European circular economy and green growth from 2020 to 2050. The new circular economy r
2019-11-13 11:34:00 Wednesday ET

The new Brexit deal can boost British pound appreciation and economic optimism. British prime minister Boris Johnson wins the parliamentary vote on his new
2018-02-23 09:35:00 Friday ET

Warren Buffett releases his annual letter to Berkshire Hathaway shareholders as of February 2018. Buffett discusses Berkshire's core cash ambition, its
2018-08-19 10:34:00 Sunday ET

The World Economic Forum warns that artificial intelligence may destabilize the financial system. Artificial intelligence poses at least a trifecta of major
2022-05-05 09:34:00 Thursday ET

Corporate payout management This corporate payout literature review rests on the recent survey article by Farre-Mensa, Michaely, and Schmalz (2014). Out